RxDoctor Payments Data

Luis Espinoza, MD

Obstetrics & Gynecology · El Dorado, KSNPI 1376646620

Payments from drug & device makers

What this record shows

19 manufacturers reported payments, led by Boston Scientific at 31.2% of the total. 2025 is the largest year on record at $2,650, 6.6 times the $400 reported in 2019. Among obstetrics & gynecology clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,881in general payments, 2019–2025

Across 127 payments — averaging $62.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Axonics, Inc.$2K
  • Johnson & Johnson$1K
  • AbbVie$921
  • Applied Medical Resources Corporation$146
  • Sumitomo Pharma America, Inc.$118
  • plus $518 from 13 others

What the payments were for

  • Travel & lodging$3,36043%
  • Food & beverage$4,52157%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,881 in reported general payments places this provider in the 90th percentile of 302 obstetrics & gynecology providers in Kansas.

See all obstetrics & gynecology providers in Kansas

Medicare billing

Part B allowed, 2024
$66,380
Medicare patients
231
Services billed
484

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron33$21,811
GemtesaVibegron31$18,796
Estradiol189$11,624
LinzessLinaclotide17$11,170
YuvafemEstradiol80$4,475
DuaveeEstrogens,conj/Bazedoxifene20$3,862
Estradiol (Twice Weekly)Estradiol20$1,799
ProgesteroneProgesterone, Micronized32$605
Oxybutynin Chloride ErOxybutynin Chloride45$501
Fluconazole44$341
Metronidazole50$267
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$203
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$65

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$118$18,79631 claims
AbbVieLinzess$921$11,17017 claims
PfizerDuavee$76$3,86220 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 302 obstetrics & gynecology providers in Kansas.

Other obstetrics & gynecology in El Dorado

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →